Back to News Page
Source: Yahoo! Finance
Yahoo Finance highlights Boomerang Ventures portfolio company Mentavi Health and its expanded online diagnostic evaluation, designed to assess a broader range of mental health conditions.
Source: EIN Presswire
Mentavi Health will present peer-reviewed validation findings at the 31st Annual National Psychopharmacology Update, highlighting its clinically studied online adult ADHD diagnostic evaluation. The Journal of Clinical Psychiatry–published study demonstrates strong agreement with traditional clinical interviews and supports responsible expansion of digital mental health access.
Source: Digital Health News
Mentavi Health has launched Mentavi Concierge, an AI-powered mental health platform designed to elevate standards of safety, transparency, and clinical oversight in digital care. The system combines advanced conversational AI with licensed clinicians, embedded safety protocols, mood tracking, and human-in-the-loop review to ensure ethical, personalized, and HIPAA-compliant support. CEO Keith Brophy emphasizes that the technology is “patient-lifting, not job-replacing,” reinforcing Mentavi’s commitment to responsible innovation in mental healthcare.
Source: Morningstar
Santa Barbara City College (SBCC) has partnered with Mentavi Health to provide rapid, clinically validated ADHD evaluations for students. Through Mentavi’s asynchronous online diagnostic process, SBCC can deliver professional assessments within days instead of weeks, helping students access federally mandated accommodations faster.
Source: Yahoo!Finance
Quintessence Psychiatry has adopted Mentavi Health’s clinically validated ADHD Diagnostic Evaluation to provide faster, more rigorous, and cost-effective assessments for adult patients. The telepsychiatry practice, led by Dr. Nona Kocher, integrates Mentavi’s asynchronous, self-directed evaluation into its workflow, reducing wait times and improving treatment planning.
Source: Morningstar
Mentavi Health CEO Keith Brophy will spotlight the company’s clinically validated ADHD diagnostic model at Tech Week Grand Rapids 2025, underscoring how trust and peer-reviewed validation set new benchmarks in digital health.
Source: The Journal of Clinical Psychiatry
Mentavi Health, a Portfolio Company of Boomerang Ventures, is the lead author of a groundbreaking study published in the Journal of Clinical Psychiatry, “Validity of an Online Assessment of Attention-Deficit/Hyperactivity Disorder Among a Real-World Sample of Adults Seeking Web-Based Mental Health Care.” The research validates the accuracy of Mentavi’s online ADHD assessment in a real-world sample of adults seeking web-based mental healthcare. Findings demonstrate strong diagnostic agreement with clinician-led interviews and highlight the tool’s high positive predictive value, providing a clinically reliable and scalable solution to expand access to ADHD evaluation.
Source: Miami Herald, Accesswire
Mentavi Health, a portfolio company of Boomerang Ventures, is closing the psychiatric care gap with its clinically validated, asynchronous ADHD diagnostic tool. Presented at the 10th World Congress on ADHD, the platform empowers primary care clinicians with fast, affordable, and evidence-based mental health evaluations.
Source: Ferris State University
Ferris State University President Bill Pink is Tech Week 2025’s co‑chairman, working with co‑chairs Mentavi Health CEO Keith Brophy and ADAC Chief Technology Officer‑Vice President of Engineering Danche Gjorgjievski.
Source: MITECHNEWS
Keith Brophy, CEO of Mentavi Health (a Boomerang Ventures portfolio company), presenting his annual “Tech Trends” report. Brophy highlights ten major technological trends shaping 2025.
Back to News Page
